Merck & Co Inc. (MRK) News Headlines

▮ More

Date

Headline

9/17/2019 7:18:19 AM Merck: FDA Grants Priority Review For Investigational Ebola Vaccine

9/17/2019 6:58:58 AM Merck Says FDA Accept BLA And Granted Priority Review For Ebola Vaccine V920

9/9/2019 9:30:03 AM Merck & Co To Present At The Morgan Stanley Conference; Webcast At 10:30 AM ET

9/4/2019 7:22:47 AM Merck: European Commission Approves KEYTRUDA, Inlyta Combination To Treat RCC

9/4/2019 7:02:22 AM Merck Says European Commission Approves KEYTRUDA In Combination With Inlyta

8/22/2019 6:51:54 AM Merck Highlights New Data From Leading Lung Cancer Clinical Development Program At IASLC 2019

8/14/2019 2:35:04 AM AstraZeneca Reports Breakthrough Therapy Designation For Calquence - Quick Facts

8/7/2019 3:50:01 AM AstraZeneca, Merck Report Positive Phase III Trial Results Of Lynparza

8/7/2019 2:08:35 AM AstraZeneca, Merck Announce Positive Results From Phase III PROfound Trial Of Lynparza

7/31/2019 8:12:47 AM Merck Says FDA Okays New Monotherapy Indication For KEYTRUDA

7/31/2019 6:47:50 AM Merck Says FDA Approves New Monotherapy Indication For KEYTRUDA

7/30/2019 7:41:29 AM Merck Lifts FY Adj. Profit View

7/30/2019 7:01:22 AM Merck & Co Q2 19 Earnings Conference Call At 8:00 AM ET

7/30/2019 6:56:40 AM Merck & Co Inc. Q2 adjusted earnings Beat Estimates

7/30/2019 6:48:17 AM Merck Q2 GAAP EPS $1.03, Non-GAAP EPS $1.30

7/29/2019 4:14:45 PM Merck Receives Positive EU CHMP Opinion For ZERBAXA 3g Dose

7/29/2019 6:52:32 AM Merck: CHMP Supports KEYTRUDA Plus Inlyta To Treat Advanced Renal Cell Carcinoma

7/29/2019 6:37:30 AM Merck: EMA Adopts Positive Opinion For KEYTRUDA In Combination With Inlyta

7/26/2019 9:53:32 AM Notable Earnings To Watch This Week - LLY, AAPL, PG, MRK, PFE, CVX

7/24/2019 11:09:38 AM Merck Announces Presentation Of Phase 2b Results For Investigational HIV-1 Therapy Islatravir